To evaluate the association between adjunctive systemic corticosteroid use and clinical outcomes in children hospitalized with orbital cellulitis, highlighting its significance in pediatric care.
Approach:
Key Findings:
Corticosteroid use did not significantly reduce hospital length of stay (mean difference −0.43 days), but was associated with increased risks of surgical intervention (RR 2.08), PICU admission (RR 1.82), and 30-day readmission (RR 2.53), raising concerns for clinical practice.
Interpretation:
Adjunctive corticosteroids do not shorten hospitalization and may increase adverse outcomes in pediatric orbital cellulitis; caution is advised in clinical application.
Limitations:
Most included studies were observational, leading to potential confounding and biases that may affect the results' reliability.
Conclusion:
High-quality randomized controlled trials are needed to clarify the role of corticosteroids in the management of pediatric orbital cellulitis, particularly focusing on specific outcomes.
Topical treatment numerically reduced progression to treatment-requiring retinopathy of prematurity in a randomized trial, although the primary endpoint was not met.
This week's research makes one thing clear: who someone is before they get sick — their relationships, their partner's health, the back of their eye — is doing a lot of work medicine is only beginning to account for.
